Neuroscientists from Johns Hopkins Medicine say they have determined how a brain cell surface molecule shapes the way certain neurons behave.
Novartis acquires Kate Therapeutics to advance gene therapies
The acquisition is set to add Kate Therapeutics’ preclinical candidates for DMD, FSHD and DM1 to Novartis’ portfolio. Credit: © 2024 Novartis AG. Novartis has